Long-term treatment of 384 adults ADHD patients with atomoxetine (Strattera, Lilly) showed that 67% responded with at least a 30% improvement and 40% had at least a 50% improvement.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Atomoxetine displays long-term efficacy in adult patients with ADHD

Newsletter